Skip to content

Hypotension After Anesthetic Induction with Remimazolam in Elderly

Comparison of the Incidence of Hypotension with Bolus Versus Continuous Remimazolam for Anesthetic Induction in Elderly Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05538741
Enrollment
62
Registered
2022-09-14
Start date
2023-07-14
Completion date
2024-06-14
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension

Brief summary

Even though remimazolam is known to be safely administered without hemodynamic instability, hypotension is the one of the common side effects of remimazolam. Because elderly patients are susceptible to hypotension due to old age, multimodality, and multiple medications, hypotension can be harmful in elderly patients. Remimazolam can be administered either bolus or continuous for anesthetic induction. In our study the investigators aimed to compare the incidence of hypotension after anesthetic induction using remimazolam by bolus injection and continuous infusion in elderly patients.

Interventions

DRUGBolus of remimazolam

0.19-0.25 mg/kg for 60-80 years old 0.14-0.19 mg/kg for \>80 years old

DRUGContinuous infusion of remimazolam

12 mg/kg/hr until loss of consciousness

Sponsors

Kangbuk Samsung Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elderly patients with age over 60 years old * scheduled for elective surgery under general anesthesia * American Society of Anesthesiology Physical Status I-III

Exclusion criteria

* Arrhythmia * Liver dysfunction * Kidney dysfunction * Uncontrolled hypertension * Uncontrolled diabetes mellitus * Allergic to benzodiazepines * Heart failure * Drug intoxication * Alcoholics * Cognitive dysfunction * Unable to understand and consent voluntarily

Design outcomes

Primary

MeasureTime frameDescription
The incidence of hypotension10 minutes after intubationSystolic blood pressure \< 90 mmHg

Secondary

MeasureTime frameDescription
The incidence of bradycardia10 minutes after intubationHeart rate \< 40 beats per minute
Number of participants with use of any vasopressors10 minutes after intubationUse of ephedrine, phenylephrine
Lowest systolic blood pressure10 minutes after intubationThe lowest systolic blood pressure measured within10 minutes after intubation
Time to loss of consciousness10 minutes after intubationTime to loss of consciousness. Loss of consciousness is assessed by the loss of response to shoulder shaking.
Total remimazolam used for anesthetic induction10 minutes after intubationSum of remimazolam used during anesthetic induction

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026